Skip to Content

Women Leadership in Biotech Summer Webinar Series | Addressing Imposter Syndrome in Biotech Leadership and How to Mitigate It

This summer, The Conference Forum will launch the four-part “Women Leadership in Biotech Summer Webinar Series” where women leaders will speak about their career journeys and offer advice around the challenges and opportunities in navigating a biotech career. This free webinar series is designed primarily for women leaders at all levels, but all are welcome. 

Former First Lady Michelle Obama, Supreme Court Justice Sonia Sotomayor, business woman, Sheryl Sandberg, actress Viola Davis have all expressed publicly that at some point in their lives they felt imposter syndrome. In fact, it has been reported that 75% of high-achieving women experience imposter syndrome at some point in their careers. The webinar series, launching June 2022, will kick off by examining what Imposter Syndrome is, why it exists, the role workplace systems can play in fostering it, other environmental causes, what to look for, how to manage and mitigate it.

More specifically:

This first webinar will be led by Halloran’s President & CEO and veteran drug development expert Laurie Halloran, as well as a group of established biotech women leaders who will share their own stories and what they did to manage and overcome Imposter Syndrome.

Laurie Halloran will serve as moderator, and other panelists include:

There is no fee to attend, but registration is required. Please visit The Conference Forum’s website to register if interested.

LSX World Congress USA | Partnering, Strategy & Investment for Life Science Executive Leaders

LSX World Congress USA will replicate the unique dynamics and high-quality senior audience that has become the hallmark of LSX events around the world. The 5th Annual event happening in Boston, MA will gather together North America’s leading Biotech, Medtech and HealthTech CEOs for a 2-day executive conference, 1-2-1 in-person partnering and showcase opportunities. The CEOs from LSX’s network will be joined by the sectors most active investors, big pharma and commercial leaders as well as a selection of the highest-quality, trusted advisors.

Halloran’s Matt Cardinal, VP of Strategy & Program Leadership, will moderate the panel “Building a ‘forever biotech’ – Exploring early foundation, sustainable capital and pipeline expansion.” This session draws on the expertise of successful biotech founders, exploring the step-by-step process, key success factors and potential pitfalls of building and growing a biotech company. The discussion will include:
• How to build a business model around a core asset
• How to raise sustainable capital including key success factors, common pitfalls and “what I wish I knew then”
• How to develop a pipeline from a single core asset

Panelists for this session also include:

The CMO Roundtable | In Partnership with Entrada Therapeutics: What Every CMO Needs to Know about Fundraising to be an Effective Officer of the Company in this Current Environment

As a CMO, do you ever feel like you’re nodding your head in conversations with other executives in your organization about the fundraising process, but in reality, aren’t comfortable asking to clarify the terminology? Many CMOs have felt uncomfortable not having enough financial knowledge and being transparent about that gap, but as an officer of the company, it’s essential to be equipped with the right insight to align on the right decisions for the next stage of growth.

Please join us for a virtual Halloran-hosted CMO Roundtable “What Every CMO Needs to Know about Fundraising to be an Effective Officer of the Company in this Current Environment” on June 30th from 12-1 pm ET to help take some of the pressure off during your financing conversations, particularly in this environment.

Your CMO Roundtable Hosts:

Nerissa will share her experience raising capital at several companies and making the transition from a private to a public company, as there are new procedures and considerations to keep in mind. Katina will share her financial knowledge as a CFO and highlight what’s essential for a CMO to know to enhance and maximize opportunities at any organization and the partnership between a CFO and CMO.

Please bring your questions and examples to share! We look forward to learning and sharing together.

NOTE: This is an invite-only event. To request an invite, please click the more details link to email Halloran’s Event Manager.

Halloran Clinical Operations Executive Breakfast | In Partnership with BSCI -Creating the Next Generation of Clinical Research Talent: Lessons Learned from the First Apprenticeship Program and Plans for Expansion

COVID-19 has impacted clinical trials for over two years now – we’ve experienced challenges across the full trial lifecycle (design, execution, and analysis) but it’s been a catalyst for change, accelerating clinical trial strategies into the 21st century as more sponsors adapt to enable more flexible, efficient clinical trials. But what changes are here to stay for the long haul and what’s the impact on for sponsors and study sites?

Bringing perspective from trials conducted or still being designed during the COVID-19 pandemic, please join a group of experts from Boston Scientific and St. Luke’s Hospital to lead the discussion at our upcoming virtual Halloran-hosted Clinical Operations Executive Breakfast on Thursday, June 16th from 8:30-10 am ET.

Introducing:

They will dive into key challenges and workshop solutions to the following scenarios:

We welcome you to join this community to listen, share your challenges, and workshop solutions together at the virtual breakfast table.

NOTE: This is an invite-only event. To request an invite, please click the more details link to email Halloran’s Event Manager.

Halloran Speaker Series | Program Management: The Key to Success for Life Sciences Companies

The Program Manager brings deep experience to support life sciences companies in achieving their goals in an efficient manner. They strategize and lead, build and execute development plans, provide tools and templates to facilitate workflow, and utilize effective team management techniques throughout all stages of a company’s product and portfolio development. The Program Manager serves an essential role for both scientific and management teams through their deep understanding of the criteria that lead to success.

The Program Manager is the single point of expertise across all functions. The Program Management role is thus a continuum, often evolving to become a portfolio and enterprise-wide program management role as a program moves from its early stages in a research laboratory to market approval and beyond. However, there are often misunderstandings around the value that a Program Manager can bring to a company. We need to clearly communicate the role and responsibilities of the Program Manager, define how the Program Manager builds the vision, strategy, and support for the product development team, and clarify how effective execution of the Program Manager role drives superior product development and contributes to a competitive advantage in the life sciences marketplace.

Please join us on Wednesday, June 15th from 2-3pm ET for the virtual Halloran-hosted Speaker Series entitled “Program Management: The Key to Success for Life Sciences Companies,” as we discuss our program management insights and highlight key examples from our experience across all stages of development.

Perspectives to be shared during the discussion:

Because this is a community conversation, please bring your questions and comments to share. We look forward to welcoming you at our Speaker Series.

Hosted By:

In-Person Clinical Business Operations Discussion Forum | How and When to Build a Clinical Business Operations Unit to Maximize Efficiency for Biotechs

The clinical operations unit in biotech companies has evolved and emerged with a variety of specialized roles that focus on the business side of clinical operations. Responsibilities in our earlier years may have been held by clinical trial managers have now been centralized into clinical business operations groups that often support the entire development organization and not just clinical operations. This function has emerged to assume the responsibilities for a range of activities including budgeting, forecasting, contracting, outsource management (sourcing, management, and governance), and even systems management. But as companies scale, there are often questions around when, why, and how to establish a clinical business operations group.

As we’ve observed these new tasks evolve to something clinical business operations related, we’re bringing on two experts who can share their experience and how they developed (or plan on developing) a clinical business operations team in response to the growing demands on their clinical operations teams.

Please join us on June 15th from 9 -10:30am ET for a small in-person Clinical Business Operations discussion forum on “How and When to Build a Clinical Business Operations Unit to Maximize Efficiency for Biotechs.”

This small roundtable style event will be led by:

• Matt Weinberg, Sr. Director, Clinical Business Operations, Agios Pharmaceuticals

• Kristen Longobardi, Vice President, Quality, Operations and Performance, Biogen

The conversation will be centered around the following questions:

Location:

Halloran Consulting Group Headquarters

22 Thomson Place, Boston, MA 02210

Coffee and breakfast will be provided

If you have any questions, please email Maria Coakley, Events Manager, at mcoakley@hallorancg.com or Meredith Piela, Marketing & Events Coordinator, is also available at mpiela@hallorancg.com.

NOTE: This is an invite-only event. To request an invite, please click the more details link to email Halloran’s Event Manager.

In-Person Focus Group In Partnership with Datacubed Health | Transforming the Patient Experience: An Interactive Product Roadmap Conversation with Datacubed Health on How to Better Collect RWE for Clinical Trials (P3, P4, and Beyond)

We recently partnered with Datacubed Health during a Halloran-hosted Clinical Operations Breakfast – an informal community of clinical operations professionals that meet monthly to discuss industry trends, challenges, and solutions over breakfast – to learn the “Three Essentials to Operationalize Decentralized Clinical Trials to Maximize Efficiency.” As clinical trials have become more reliant on remote and virtual connections, the Datacubed app provides a way to maintain momentum, regardless of the patient’s ability or need to visit a study site in-person. The interactions through the app guides participants through the study process and enables operationalization for decentralized trials.

We are excited to further the conversation and host a small focus group with Datacubed so that you can share your feedback and preferences on the patient experience to solve for industry challenges together. Given the speed and complexity of our industry’s work, Datacubed is eager to listen to your perspectives as they continue to enhance their tool based on industry feedback.

Please join us on June 7th from 8:30-10 am ET for a small in-person focus group “Transforming the Patient Experience: An Interactive Product Roadmap Conversation with Datacubed Health on How to Better Collect RWE for Clinical Trials (P3, P4, and Beyond).”

The conversation will be centered around the following questions:

Location:

Halloran Consulting Group Headquarters

22 Thomson Place, Boston, MA 02210

Coffee and breakfast will be provided

If you have any questions, please email Maria Coakley, Events Manager.

NOTE: This is an invite-only event. To request an invite, please click the more details link to email Halloran’s Event Manager.

The CMO Roundtable | In Partnership with ASC Therapeutics: Raising Money in the Biotech Financing Downturn: How to Prepare and Plan as a CMO

The wave of a record-breaking two years for biotech fundraising has significantly slowed as we observe the downward trend of stock valuations and the difficulties of raising capital. Over the past year, the financing for biotech companies has hit some bumps in the road and small companies, particularly, are feeling those challenges as they experience tight budgets with the same product development demands.

This challenging market has initiated rethinking for many company leaders – prioritizing and modifying financing strategy, development timelines and priorities, and overall growth plans to tighten internal operations – that wasn’t necessary a year ago.

Oscar Segurado, CMO at ASC Therapeutics, is in the thick of this situation and will be bringing on an investor perspective at our Halloran-hosted CMO Roundtable on Thursday, May 26th from 12 – 1 pm ET on “Raising Money in the Biotech Financing Downturn: How to Prepare and Plan as a CMO” to share insight and experience. Other panelists in the roundtable include:

In the spirit of sharing and solving together, they’ll highlight:

Ultimately, you may need to pitch more, prioritize programs, and prepare for some potentially risky investments. These are difficult decisions, and as a CMO, you’ll likely be at the decision table. Please join our CMO Roundtable for an interactive discussion. We look forward to seeing you soon.

NOTE: This is an invite-only event. To request an invite, please click the more details link to email Halloran’s Event Manager.

The AGXPE 2022 Conference | Exploring the Frontiers of GXP

The AGXPE 2022 Conference will focus on the current state of regulations, challenges, and best practices across the GxP spectrum.  

The AGXPE conferences provide robust content that keeps teams of Innovation, Quality and Compliance, IT Quality Systems, Data Validation, and Training, informed and educated on current compliance issues. The conference sessions provide learning and development opportunities for both the speakers and the attendees. Presenters provide new and innovative training ideas, hot topics, tools, tips, and techniques that work.

The Halloran team is excited to speak at this year’s event in two talk tracks. Jamie Chalfin and Sheri Jacobsen will discuss “How to Prepare for GCP R3 When You’re Still Struggling with R2” and Terrina Grove and Joseph Delfs will discuss “Evolving your QMS from GMP to GxP.”

LSX World Congress| Partnering, Strategy & Investment for Life Science Executive Leaders

The 8th LSX World Congress gathers the founders and CEOs of innovative start-ups through to healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

It is an industry-leading gathering with qualified 1:1 partnering at its core, connecting the biotech, healthtech and medtech industry c-suite with the sector’s most active pharma, investors and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward.

Halloran’s Matt Cardinal, VP of Strategy & Program Leadership, will moderate the panel “Dressing for Success Early as a Biopharma Start-Up” discussing how identifying the structural, technical, and development challenges to plan for in trying to get to the next level are widely complex. Matt will speak with newly formed companies to learn how they worked through their planning process and set themselves up for their next phase of growth, issues they faced along the way, and the realities they face as a start-up.